این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
پنجشنبه 4 دی 1404
Iranian Journal of Pediatric Hematology and Oncology
، جلد ۸، شماره ۳، صفحات ۱۵۳-۱۶۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
A Comparison between the Anticancer Activities of Free Paclitaxel and Paclitaxel-Loaded Niosome Nanoparticles on Human Acute Lymphoblastic Leukemia Cell Line Nalm-6
چکیده انگلیسی مقاله
Background: Niosomes or Nonionic surfactant vesicles are nano vehicles utilized in drug delivery systems, especially in cancer therapy. In this study, these vesicles were applied as delivery system for anticancer drug, paclitaxel and then, its anticancer activities was compared with free paclitaxel on Human Acute Lymphoblastic Leukemia (ALL) cell line Nalm-6. Materialas and Methods: In this exprimental study, paclitaxel loaded niosome was prepared by thin film hydration method. The characterization tests included dynamic light scattering (DLS) and UV-Vis spectrophotometry were employed to evaluate the quality of the nanocarriers. Cytotoxicity of niosomal paclitaxel nanoparticles and free paclitaxel on human acute lymphoblastic leukemia cell line Nalm-6 after 24 hours were studied by MTT assay to determine cell viability. Results: Percent of encapsulation paclitaxel prepared with sorbitane monostearate, cholesterol, and DSPE-mPEG 2000 was 97.21 %. In addition, the polydispersity index, mean size diameter, and zeta potentials of niosomal paclitaxel nanoparticles were found to be 0.244 ± 0.011, 106.3 ± 1.5 nm, and -26.03 ± 1.34; respectively. Paclitaxel released from nanoniosome in 72 h was 19.81 %. The results demonstrated that a 2.5∼fold reduction in paclitaxel concentration was measured when the paclitaxel administered in nanoniosome compared to free paclitaxel solution in human acute lymphoblastic leukemia cell line Nalm-6. Conclusion: As a result, the nanoparticle-based formulation of paclitaxel has high potential as an adjuvant therapy for clinical usage in human acute lymphoblastic leukemia therapy.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
| Ashraf Alemi
Department of Clinical Biochemistry, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
دانشگاه علوم پزشکی یزد
| Majid Farrokhifar
Department of Pediatrics, Sabzevar University of Medical Sciences, Sabzevar, Iran
دانشگاه علوم پزشکی سبزوار
| Hadi Zare-Zardini
Hematology and Oncology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
دانشگاه علوم پزشکی یزد
| Mojtaba Haghi Karamallah
Biotechnology Research Center, International Campus, Shahid Sadoughi University of Medical Science, Yazd, Iran
دانشگاه علوم پزشکی یزد
نشانی اینترنتی
http://ijpho.ssu.ac.ir/browse.php?a_code=A-10-575-3&slc_lang=fa&sid=1
فایل مقاله
اشکال در دسترسی به فایل - ./files/site1/rds_journals/202/article-202-639472.pdf
کد مقاله (doi)
زبان مقاله منتشر شده
fa
موضوعات مقاله منتشر شده
تخصصی
نوع مقاله منتشر شده
پژوهشی
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات